243 related articles for article (PubMed ID: 17198274)
41. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
[TBL] [Abstract][Full Text] [Related]
42. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
[TBL] [Abstract][Full Text] [Related]
43. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
[TBL] [Abstract][Full Text] [Related]
44. Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia.
Rogers NM; Lawton PD; Jose MD
Nephrology (Carlton); 2011 Nov; 16(8):777-83. PubMed ID: 21707840
[TBL] [Abstract][Full Text] [Related]
45. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection.
Rouschop KM; Roelofs JJ; Rowshani AT; Leemans JC; van der Poll T; Ten Berge IJ; Weening JJ; Florquin S
Nephrol Dial Transplant; 2005 Oct; 20(10):2248-54. PubMed ID: 16166750
[TBL] [Abstract][Full Text] [Related]
46. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
47. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance.
Gärtner V; Eigentler TK; Viebahn R
Transplantation; 2006 Apr; 81(7):986-91. PubMed ID: 16612273
[TBL] [Abstract][Full Text] [Related]
48. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
[TBL] [Abstract][Full Text] [Related]
49. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
50. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
51. Expression of the chemokine receptor CCR1 in human renal allografts.
Mayer V; Hudkins KL; Heller F; Schmid H; Kretzler M; Brandt U; Anders HJ; Regele H; Nelson PJ; Alpers CE; Schlöndorff D; Segerer S
Nephrol Dial Transplant; 2007 Jun; 22(6):1720-9. PubMed ID: 17298994
[TBL] [Abstract][Full Text] [Related]
52. Effects of body mass index at transplant on outcomes of kidney transplantation.
Chang SH; Coates PT; McDonald SP
Transplantation; 2007 Oct; 84(8):981-7. PubMed ID: 17989603
[TBL] [Abstract][Full Text] [Related]
53. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
[TBL] [Abstract][Full Text] [Related]
54. C4d-the witness of humoral rejection.
de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
[TBL] [Abstract][Full Text] [Related]
55. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.
Veale JL; Liang LW; Zhang Q; Gjertson DW; Du Z; Bloomquist EW; Jia J; Qian L; Wilkinson AH; Danovitch GM; Pham PT; Rosenthal JT; Lassman CR; Braun J; Reed EF; Gritsch HA
Hum Immunol; 2006 Oct; 67(10):777-86. PubMed ID: 17055354
[TBL] [Abstract][Full Text] [Related]
56. A retrospective study of plasma cell infiltrates in explanted renal allografts.
Xu X; Shi B; Cai M; Han Y; Wang Q; Xu L; Xiao L; Zhou W
Transplant Proc; 2008 Jun; 40(5):1366-70. PubMed ID: 18589107
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis of acute humoral rejection using immunofluorescence in renal allograft biopsies- one step towards better understanding!
Vanikar AV; Trivedi H; Patel RD; Kanodia KV; Trivedi VB; Shah PR; Gupta SB; Dabhi M; Gumber M; Goplani K
Indian J Pathol Microbiol; 2007 Jul; 50(3):502-6. PubMed ID: 17883118
[TBL] [Abstract][Full Text] [Related]
58. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
59. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
60. Occurrence of urinary tract infection in patients with renal allograft biopsies showing neutrophilic tubulitis.
Fonseca LE; Shapiro R; Randhawa PS
Mod Pathol; 2003 Apr; 16(4):281-5. PubMed ID: 12692191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
